These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 17083031
21. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, Williamson J, Shi YP, Feikin DR, Marston B, Brooks JT, Poe A, Zhou Z, Ochieng B, Mintz E, Slutsker L. Am J Trop Med Hyg; 2008 Sep; 79(3):320-30. PubMed ID: 18784222 [Abstract] [Full Text] [Related]
26. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, Malamba S, Bunnell R. AIDS Behav; 2006 Jul 10; 10(4 Suppl):S85-93. PubMed ID: 16791525 [Abstract] [Full Text] [Related]
27. Protease inhibitor treatment of HIV-1-infected women may protect against extreme prematurity and very low birth weight. Beckerman KP. J Infect Dis; 2007 Oct 15; 196(8):1270-1; author reply 1271. PubMed ID: 17955447 [No Abstract] [Full Text] [Related]
28. Prophylactic use of cotrimoxazole against opportunistic infections in HIV-positive patients: knowledge and practices of health care providers in Côte d'Ivoire. Brou H, Desgrées-du-Loû A, Souville M, Moatti JP, Msellati P, Initiative Evaluation Group in Côte d'Ivoire. AIDS Care; 2003 Oct 15; 15(5):629-37. PubMed ID: 12959812 [Abstract] [Full Text] [Related]
31. Role of trimethoprim-sulphamethoxazole in preventing HIV-associated bacteraemia. Tumbarello M, Tacconelli E, Cauda R, Ortona L. AIDS; 1997 Jul 15; 11(8):1070-1. PubMed ID: 9223752 [No Abstract] [Full Text] [Related]
33. The role of cotrimoxazole in HIV-coinfected TB patients: some concerns. Kalk A. Int J Tuberc Lung Dis; 2005 Mar 15; 9(3):349; author reply 349-50. PubMed ID: 15786903 [No Abstract] [Full Text] [Related]
34. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. World Health Organization, UNAIDS. Afr Health Sci; 2001 Aug 15; 1(1):30-1. PubMed ID: 12833907 [No Abstract] [Full Text] [Related]
35. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. Yang J, Xie RH, Krewski D, Wang YJ, Walker M, Wen SW. Int J Infect Dis; 2011 May 15; 15(5):e336-41. PubMed ID: 21345707 [Abstract] [Full Text] [Related]
36. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. US Public Health Service, Infectious Diseases Society of America, Prevention of Opportunistic Infections Working Group. Infect Dis Obstet Gynecol; 2002 May 15; 10(1):3-64. PubMed ID: 12090361 [No Abstract] [Full Text] [Related]
37. Consensus on use of co-trimoxazole. Trop Doct; 2001 Jul 15; 31(3):189-90. PubMed ID: 11444358 [No Abstract] [Full Text] [Related]
39. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study. Martin F, Taylor GP. J Infect Dis; 2007 Aug 15; 196(4):558-61. PubMed ID: 17624841 [Abstract] [Full Text] [Related]